Chemical hybridization of glucagon and thyroid hormone optimizes therapeutic impact for metabolic disease
While isolated laboratory studies show one thing, the reality of human biology is much more integrated
A triple combination targeting epigenetic dysregulation and apoptotic resistance, comprising iadademstat (LSD1 inhibitor), azacitidine (a hypomethylating agent), and venetoclax (a BCL-2 inhibitor), is under investigation in a phase I trial for acute myeloid leukemia (NCT06357182)
The Journal of the American Medical Association recently published diet and exercise guidance for people taking GLP-1s (3): Source: Mehrtash F, Dushay J, Manson JE
How to use Lipo B12 Use as prescribed Common Side Effects Headaches Nausea Diarrhea Dizziness Irritability Lightheadedness Allergic reactions Whats Included Rx Consultation Discuss your treatment plan with one of our licensed practitioners
Clin Res Hepatol Gastroenterol